Page 32 - The role of advanced echocardiography in patients with ischemic heart disease - Rachid Abou

Chapter one. General introduction and outline of the thesis
Severe Aortic Stenosis: Natural Course and Prognostic Value. JAMA Cardiol 2018;3(9):839-47. doi: 10.1001/jamac- ardio.2018.2288
34. Weidemann F, Herrmann S, Stork S, et al. Impact of myocardial fibrosis in pa- tients with symptomatic severe aortic stenosis. Circulation 2009;120(7):577- 84. doi: 10.1161/CIRCULATIONA- HA.108.847772
35. Magne J, Cosyns B, Popescu BA, et al. Distribution and Prognostic Signifi- cance of Left Ventricular Global Lon- gitudinal Strain in Asymptomatic Sig- nificant Aortic Stenosis: An Individual Participant Data Meta-Analysis. JACC Cardiovasc Imaging 2019;12(1):84-92. doi: 10.1016/j.jcmg.2018.11.005
36. Ewe SH, Haeck ML, Ng AC, et al. De- tection of subtle left ventricular systolic dysfunction in patients with significant aortic regurgitation and preserved left ventricular ejection fraction: speck- le tracking echocardiographic anal- ysis. Eur Heart J Cardiovasc Imaging 2015;16(9):992-9. doi: 10.1093/ehjci/ jev019
37. Smedsrud MK, Pettersen E, Gjesdal O, et al. Detection of left ventricular dys- function by global longitudinal systolic strain in patients with chronic aortic regurgitation. J Am Soc Echocardiogr 2011;24(11):1253-9. doi: 10.1016/j. echo.2011.08.003
38. Plana JC, Galderisi M, Barac A, et al. Ex- pert consensus for multimodality imag- ing evaluation of adult patients during and after cancer therapy: a report from
the American Society of Echocardiog- raphy and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2014;15(10):1063- 93. doi: 10.1093/ehjci/jeu192
39. Verseckaite R, Mizariene V, Mont- vilaite A, et al. The predictive value of left ventricular myocardium me- chanics evaluation in asymptomat- ic patients with aortic regurgitation and preserved left ventricular ejection fraction. A long-term speckle-tracking echocardiographic study. Echocardiog- raphy 2018;35(9):1277-88. doi: 10.1111/ echo.14030
40. Negishi K, Negishi T, Hare JL, et al. In- dependent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 2013;26(5):493-8. doi: 10.1016/j.echo.2013.02.008
41. Sawaya H, Sebag IA, Plana JC, et al. Assessment of echocardiography and biomarkers for the extended predic- tion of cardiotoxicity in patients treat- ed with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012;5(5):596-603. doi: 10.1161/CIR- CIMAGING.112.973321
42. Altiok E, Neizel M, Tiemann S, et al. Layer-specific analysis of myocardial deformation for assessment of infarct transmurality: comparison of strain-en- coded cardiovascular magnetic reso- nance with 2D speckle tracking echo- cardiography. Eur Heart J Cardiovasc Imaging 2013;14(6):570-8. doi: 10.1093/ ehjci/jes229
26